IDNTStudy Design

• 1,715 patients with hypertension, type 2 diabetes, and proteinuria ³ 900 mg/day

Double-blind Treatment

Up to 5 weeks

Screening/Enrollment

Control group*

Amlodipine*

Minimum follow-up: approximately 2 years (average follow-up 2.6 years)

Irbesartan*

* Adjunctive antihypertensive therapies (excluding ACE inhibitors, angiotensin II receptor antagonists, and calcium channel blockers) could be added to all groups to help achieve equal blood pressure levels.

Lewis EJ et al. N Engl J Med 2001;345:851-860.

Diapositiva anterior

Diapositiva siguiente

Ir a la primera diapositiva

Ver versión gráfica